Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2026-05-16 @ 8:39 PM
Study NCT ID:
NCT06004167
Status:
COMPLETED
Last Update Posted:
2025-12-09
First Post:
2023-08-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)
Sponsor:
Massachusetts General Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lymphoma, B-Cell | View |
| None | Relapsed Cancer | View |
| None | Refractory Lymphoma | View |
| None | Diffuse Large B Cell Lymphoma | View |
| None | Mediastinal Large B-cell Lymphoma | View |
| None | High-grade B-cell Lymphoma | View |
| None | Follicular Lymphoma | View |
| None | Mantle Cell Lymphoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Relapsed/Refractory B-cell Lymphoma | View |